TrialThe Journal of infectious diseases2010

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

Hannah Kibuuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.